Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19

通过行为和社会科学研究优化 COVID-19 高发病率的少数族裔社区对 SARS-CoV-2 保护性疫苗的接种

基本信息

  • 批准号:
    10490972
  • 负责人:
  • 金额:
    $ 61.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-19 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Intensive efforts are underway to develop a vaccine protective against SARS-CoV-2 infection, and hope is high that a safe and effective vaccine will soon be available. However, development of a vaccine does not ensure its uptake on the scale needed to bring COVID-19 under control. In the United States, communities of color are disproportionately burdened by COVID-19 diagnosis, serious illness, and death. However, experience in areas such as influenza vaccination portends that COVID-19 vaccine uptake will be lower in African American communities hard-hit by the disease. Racial disparities in influenza vaccination have been linked to individual factors (including low vaccine awareness, medical mistrust, fears and vaccine skepticism); structural barriers (such as not having an accessible primary health care provider); peer group norms that do not sufficiently support getting vaccinated; and social, economic, and life stressors that contribute to many health inequities. Similar but also unique factors are likely to undermine acceptance of COVID-19 vaccination in racial minority communities. Community-engaged research must be undertaken now—and at a point before a vaccine is widely available—to understand and address community concerns and to develop strategies to prevent racial disparities in COVID-19 vaccination uptake. The planned research will be undertaken in Milwaukee by a team of behavioral and social scientists in a collaboration with an established federally qualified community health center serving low-income inner-city residents. The research will use mixed methods to identify minority community concerns regarding COVID-19 vaccination; to determine factors that influence strength of community members’ intentions to vaccinate; and to pilot test and establish the feasibility and acceptability of a virtually-delivered intervention that engages community social influencers to address vaccine concerns and endorse vaccine benefits within their social networks. The work will be undertaken in an accelerated manner in three distinct but interrelated phases, all with samples diverse in age and gender: (1) focus groups conducted with 160 African American inner-city community members to elicit COVID-19 vaccine beliefs; perceived risks, benefits, and norms; and factors that would impede or facilitate vaccination; (2) an online quantitative survey study that will enroll 700 community members from zip codes with greatest SARS-CoV-2 rates and will measure respondents’ intentions to vaccinate and test the influence on those intentions of theory-based predictors including perceived COVID-19 threat; perceived vaccination benefits, barriers, and self-efficacy, as well as identifying preferred settings for vaccination; and (3) a feasibility and acceptability pilot test of a virtually-delivered intervention that trains and enlists personally-known and trusted neighborhood social influencers to address the COVID-19 vaccination concerns of their friends, family members, neighbors, coworkers, and social media followers, and that supports informed decisions about vaccination. This research will characterize vaccine concerns and identify strategies that can optimize vaccine uptake in racial minority communities vulnerable to COVID-19.
抽象的 目前正在加紧努力开发一种预防 SARS-CoV-2 感染的疫苗,并希望 人们普遍认为安全有效的疫苗很快就会问世。然而,疫苗的研发并不 确保其吸收规模达到控制 COVID-19 所需的规模。在美国,社区 有色人种因 COVID-19 诊断、严重疾病和死亡而承受着不成比例的负担。然而,经验 在流感疫苗接种等领域,非洲裔美国人对 COVID-19 疫苗的接种率将较低 受该疾病重创的社区。流感疫苗接种的种族差异与个人有关 因素(包括疫苗意识低、医疗不信任、恐惧和疫苗怀疑);结构性障碍 (例如没有可用的初级卫生保健提供者);同伴群体规范还不够充分 支持接种疫苗;以及导致许多健康不平等的社会、经济和生活压力。 类似但又独特的因素可能会影响少数族裔对 COVID-19 疫苗接种的接受度 社区。现在就必须开展社区参与的研究——而且是在疫苗广泛普及之前的某个时刻 可用——了解和解决社区关注的问题,并制定防止种族歧视的策略 COVID-19 疫苗接种情况存在差异。计划中的研究将由一个团队在密尔沃基进行 行为和社会科学家与已建立的联邦合格社区健康中心合作 服务于低收入内城居民。该研究将使用混合方法来识别少数群体社区 对 COVID-19 疫苗接种的担忧;确定影响社区成员强度的因素 接种疫苗的意愿;并进行试点测试并确定虚拟交付的可行性和可接受性 让社区社会影响者参与解决疫苗问题并支持疫苗的干预措施 他们的社交网络中的利益。这项工作将在三个不同但不同的领域加速进行 相互关联的阶段,所有样本的年龄和性别各异:(1) 对 160 名非洲人进行焦点小组讨论 美国内城区社区成员激发对 COVID-19 疫苗的信念;感知到的风险、收益和 规范;以及阻碍或促进疫苗接种的因素; (2) 在线定量调查研究 从 SARS-CoV-2 发病率最高的邮政编码地区招募 700 名社区成员,并将测量受访者的 接种疫苗的意图并测试基于理论的预测因素对这些意图的影响,包括感知 COVID-19 威胁;感知疫苗接种的好处、障碍和自我效能,以及确定首选疫苗接种 疫苗接种场所; (3) 对虚拟实施的干预措施进行可行性和可接受性试点测试 培训并招募个人知名且值得信赖的邻里社会影响者来应对 COVID-19 他们的朋友、家人、邻居、同事和社交媒体关注者对疫苗接种的担忧,以及 支持有关疫苗接种的明智决策。这项研究将描述疫苗问题的特征并确定 可以优化易受 COVID-19 影响的少数族裔社区的疫苗接种情况的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yuri A Amirkhanian其他文献

Yuri A Amirkhanian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yuri A Amirkhanian', 18)}}的其他基金

Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19
通过行为和社会科学研究优化 COVID-19 高发病率的少数族裔社区对 SARS-CoV-2 保护性疫苗的接种
  • 批准号:
    10628038
  • 财政年份:
    2021
  • 资助金额:
    $ 61.76万
  • 项目类别:
Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19
通过行为和社会科学研究优化 COVID-19 高发病率的少数族裔社区对 SARS-CoV-2 保护性疫苗的接种
  • 批准号:
    10273271
  • 财政年份:
    2021
  • 资助金额:
    $ 61.76万
  • 项目类别:
Mobilizing Social Network Resources for HIV Care Support: Development and Testing of an Intervention for HIV-Positive MSM
动员社交网络资源支持艾滋病毒护理:针对艾滋病毒阳性男男性行为者的干预措施的开发和测试
  • 批准号:
    10531874
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
Mobilizing Social Network Resources for HIV Care Support: Development and Testing of an Intervention for HIV-Positive MSM in St. Petersburg, Russia
动员社交网络资源支持艾滋病毒护理:俄罗斯圣彼得堡艾滋病毒阳性男男性接触者干预措施的开发和测试
  • 批准号:
    10304207
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
Mobilizing Social Network Resources for HIV Care Support: Development and Testing of an Intervention for HIV-Positive MSM in St. Petersburg, Russia
动员社交网络资源支持艾滋病毒护理:俄罗斯圣彼得堡艾滋病毒阳性男男性接触者干预措施的开发和测试
  • 批准号:
    10160227
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
Increasing PrEP Use in High-Risk Social Networks of African American MSM in Underserved Low-Uptake Cities
在服务不足、使用率低的城市中,增加非洲裔美国男男性接触者高风险社交网络中 PrEP 的使用
  • 批准号:
    10200891
  • 财政年份:
    2017
  • 资助金额:
    $ 61.76万
  • 项目类别:
Increasing PrEP Use in High-Risk Social Networks of African American MSM in Underserved Low-Uptake Cities
在服务不足、使用率低的城市中,增加非洲裔美国男男性接触者高风险社交网络中 PrEP 的使用
  • 批准号:
    10090689
  • 财政年份:
    2017
  • 资助金额:
    $ 61.76万
  • 项目类别:
Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria
HIV 检测的社区干预
  • 批准号:
    8991823
  • 财政年份:
    2015
  • 资助金额:
    $ 61.76万
  • 项目类别:
Community Intervention for HIV Testing & Care Linkage Among Young Roma MSM in Bulgaria
HIV 检测的社区干预
  • 批准号:
    9518131
  • 财政年份:
    2015
  • 资助金额:
    $ 61.76万
  • 项目类别:
Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria
HIV 检测的社区干预
  • 批准号:
    9314611
  • 财政年份:
    2015
  • 资助金额:
    $ 61.76万
  • 项目类别:

相似海外基金

HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
  • 批准号:
    495195
  • 财政年份:
    2023
  • 资助金额:
    $ 61.76万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10013921
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10181081
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
  • 批准号:
    10166309
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10597008
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10386931
  • 财政年份:
    2020
  • 资助金额:
    $ 61.76万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9921510
  • 财政年份:
    2019
  • 资助金额:
    $ 61.76万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9753631
  • 财政年份:
    2019
  • 资助金额:
    $ 61.76万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    10265667
  • 财政年份:
    2019
  • 资助金额:
    $ 61.76万
  • 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
  • 批准号:
    364681
  • 财政年份:
    2017
  • 资助金额:
    $ 61.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了